Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024

Rhea-AI Summary

Vistagen (NASDAQ: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company, has announced a conference call and webcast scheduled for August 13, 2024, at 2:00 p.m. Pacific Time. The purpose of this event is to report the company's fiscal year 2025 first quarter results for the period ended June 30, 2024, and provide a corporate update.

Investors and interested parties can access the call via a toll-free US number (1-877-407-9716) or an international dial-in (1-201-493-6779), using the Conference ID: 13748020. A webcast will also be available. Following the call, a telephone playback will be accessible using the replay access ID number 13748020.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vistagen (NASDAQ: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today announced it will host a conference call and webcast on Tuesday, August 13, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2025 first quarter ended June 30, 2024 and provide a corporate update.

Event: Vistagen Fiscal Year 2025 First Quarter Corporate Update Conference Call
Date: Tuesday, August 13, 2024
Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
US Dial-in (Toll-free): 1-877-407-9716
TOLL/International Dial-in: 1-201-493-6779
Conference ID: 13748020
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1680978&tp_key=f7af16cbaa

An audio webcast of the conference call will also be available via the link provided above. Participants should access this webcast site 10 minutes before the start of the call. In addition, a telephone playback of the call will be available after approximately 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time) on Tuesday, August 13, 2024. To listen to the replay, call toll-free 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally (toll). Please use the replay access ID number 13748020.

About Vistagen

Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on its pioneering approach and deep understanding of nose-to-brain neurocircuitry. Designed exclusively as nasal sprays administered at microgram level doses, Vistagen’s diversified pipeline of pherine product candidates rapidly activate chemosensory neurons in the nasal cavity to impact olfactory system and brain neurocircuitry. Favorable safety profiles have been observed in all clinical studies of Vistagen’s pherine product candidates completed to date. Vistagen’s neuroscience pipeline also includes an oral prodrug with the potential to modulate NMDA receptor activity in multiple neurological conditions, such as levodopa-induced dyskinesia associated with Parkinson’s disease therapy and neuropathic pain. At Vistagen, we are passionate about creating novel and differentiated treatments that set new standards of care for millions of people living with anxiety, depression, and other neurological disorders. Connect at www.Vistagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240806711001/en/

Investors:

Mark A. McPartland

Vistagen Therapeutics

markmcp@vistagen.com

Media:

Caren Scannell

Vistagen Therapeutics

cscannell@vistagen.com

Source: Vistagen

FAQ

When will Vistagen (VTGN) report its fiscal year 2025 first quarter results?

Vistagen (VTGN) will report its fiscal year 2025 first quarter results on August 13, 2024, during a conference call and webcast scheduled for 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

How can investors access Vistagen's (VTGN) fiscal year 2025 Q1 earnings call?

Investors can access Vistagen's (VTGN) fiscal year 2025 Q1 earnings call via phone (US toll-free: 1-877-407-9716, International: 1-201-493-6779, Conference ID: 13748020) or through a webcast available on the company's website.

What period does Vistagen's (VTGN) fiscal year 2025 first quarter cover?

Vistagen's (VTGN) fiscal year 2025 first quarter covers the period ended June 30, 2024.

Will there be a replay available for Vistagen's (VTGN) Q1 FY2025 earnings call?

Yes, a telephone playback of Vistagen's (VTGN) Q1 FY2025 earnings call will be available after approximately 5:00 p.m. Pacific Time on August 13, 2024. The replay can be accessed using the ID number 13748020.